After treatment, patients with stage IIIB rectal cancer can obtain a five-year survival rate of about 60%, so not almost all of them can be cured.
Rectal cancer is a common malignant tumor of gastrointestinal tract, and the occurrence of the disease is related to a variety of factors such as bad dietary habits and heredity. Stage IIIB is one of the clinical stages, which represents various conditions such as the tumor has penetrated into the intrinsic muscle layer and reached the subplasma layer; more than 7 regional lymph nodes metastasis have occurred; and there is no distant metastasis.
In this period, if there is a chance of surgery and the patient can tolerate the surgery, surgical resection is feasible, and after the surgery, radiotherapy, chemotherapy, targeted therapy and other therapies are supplemented. After active treatment, patients with stage IIIB rectal cancer can obtain a five-year survival rate of about 60%. However, some of them also have tumor recurrence and metastasis after surgery, so it is recommended to follow up regularly after surgery to detect problems in time and treat them actively.
Rectal cancer stage IIIB is recommended to consult the doctor in time, choose the appropriate treatment plan under the doctor’s guidance, and treat actively in order to prolong the survival period and improve the prognosis.